If we don’t address these inequities now, genome-editing cures for rare genetic diseases may be siloed in high-income countries.
, genome editing therapies appear to be on course to further amplify existing global health inequities., recognizing that as genome editing technology progresses, many countries are poised to be left behind. If not addressed, patients with rare genetic diseases may be left finding their cures siloed in high-income countries where hospitals have the sophisticated equipment, trained staff, and payment structures necessary to offer these therapies.
for beta-thalassaemia, a rare blood disease, from European countries over disagreements about price setting, signaling the difficulty of bringing these expensive, lifesaving therapies to patients.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
How An Accidental Entrepreneur Sold His Business For Seven FiguresTo help his patients with neck pain, physical therapist Steve Sudell decided to build his own medical device to relieve it--and soon found himself running a multimillion dollar business.
Read more »
Here's why the first official figures on Latinos in the media look better than some expectedLatinos remain widely underrepresented in the media and entertainment industries, according to preliminary results of a federal study.
Read more »
Vladimir Putin snubs Joe Biden's virtual COVID summitJoe Biden is set to convene a virtual summit of world leaders and global health officials to defeat COVID-19 on Wednesday, September 22.
Read more »
Zoom’s Nearly $15 Billion Deal for Five9 Under U.S. Government Review Over China TiesThe U.S. is reviewing Zoom’s deal to buy American software company Five9, citing potential national-security risks posed by the videoconferencing giant’s ties to China
Read more »
Vicarious Surgical Starts Trading As It Prepares To Launch Its Surgical Robots — And Take On IntuitiveI am a New York based health and science reporter and a graduate from Columbia’s School of Journalism with a master's in science and health reporting. I write on infectious diseases, global health, gene editing tools, intersection of public health and global warming. Previously, I worked as a health reporter in Mumbai, India, with the Hindustan Times, a daily newspaper where I extensively reported on drug resistant infections such as tuberculosis, leprosy and HIV. I also reported stories on medical malpractice, latest medical innovations and public health policies. I have a master’s in biochemistry and a bachelor’s degree in zoology. My experience of working in a molecular and a cell biology laboratory helped me see science from researcher's eye. In 2018 I won the EurekAlert! Fellowships for International Science Reporters. My Twitter account aayushipratap
Read more »
Vicarious Surgical Starts Trading As It Prepares To Launch Its Surgical Robots — And Take On IntuitiveI am a New York based health and science reporter and a graduate from Columbia’s School of Journalism with a master's in science and health reporting. I write on infectious diseases, global health, gene editing tools, intersection of public health and global warming. Previously, I worked as a health reporter in Mumbai, India, with the Hindustan Times, a daily newspaper where I extensively reported on drug resistant infections such as tuberculosis, leprosy and HIV. I also reported stories on medical malpractice, latest medical innovations and public health policies. I have a master’s in biochemistry and a bachelor’s degree in zoology. My experience of working in a molecular and a cell biology laboratory helped me see science from researcher's eye. In 2018 I won the EurekAlert! Fellowships for International Science Reporters. My Twitter account aayushipratap
Read more »